WO2002055127A9 - Nerve stimulator output control needle with depth determination capability and method of use - Google Patents

Nerve stimulator output control needle with depth determination capability and method of use

Info

Publication number
WO2002055127A9
WO2002055127A9 PCT/US2001/043333 US0143333W WO02055127A9 WO 2002055127 A9 WO2002055127 A9 WO 2002055127A9 US 0143333 W US0143333 W US 0143333W WO 02055127 A9 WO02055127 A9 WO 02055127A9
Authority
WO
WIPO (PCT)
Prior art keywords
needle
nerve stimulator
current
control mechanism
variable control
Prior art date
Application number
PCT/US2001/043333
Other languages
French (fr)
Other versions
WO2002055127A3 (en
WO2002055127A2 (en
Inventor
Joan M Cory
Philip C Cory
Original Assignee
Ckm Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ckm Diagnostics Inc filed Critical Ckm Diagnostics Inc
Priority to JP2002555859A priority Critical patent/JP2004522497A/en
Priority to CA002429572A priority patent/CA2429572A1/en
Priority to EP01989097A priority patent/EP1404214A2/en
Priority to AU2002243217A priority patent/AU2002243217B2/en
Publication of WO2002055127A2 publication Critical patent/WO2002055127A2/en
Publication of WO2002055127A9 publication Critical patent/WO2002055127A9/en
Publication of WO2002055127A3 publication Critical patent/WO2002055127A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4887Locating particular structures in or on the body
    • A61B5/4893Nerves

Definitions

  • This invention relates to a nerve-stimulating needle with fingertip control of stimulator current output and visual as well as electrical depth determination ability.
  • Anesthesiologists commonly use nerve stimulators and insulated needles for the purpose of locating peripheral nerves, or nerve plexuses, for the performance of regional anesthesia procedures. This procedure is discussed in Nloka JD et al., "A National Survey On Practice Patterns In The Use Of Peripheral Nerve Stimulators In Regional Anesthesia," The Internet Journal of Anesthesiology, Vol. 3, No. 4, 1999.
  • nerve stimulators reduces the potential for nerve injury since direct contact with the nerve is not required for performance ofthe anesthetic. This is in contrast to the alternative method of seeking paresthesias to confirm needle position. Paresthesias are provoked by directly disturbing the nerve. If such needle to nerve contact can be avoided, direct needle trauma should be reduced.
  • the available nerve stimulators have differing output characteristics.
  • the shape of the pulse is typically square or nearly so.
  • the pulse widths vary from 40 microseconds ( ⁇ s) to 2 milliseconds (ms).
  • Frequency selections for these stimulators range from 1.0 Hertz (Hz) to 100 Hz, in step gradations rather than continuously.
  • Stimulators that are manufactured specifically for regional anesthesia applications typically do not have frequency options greater than 5 Hz.
  • the stimulators that serve as both nerve stimulators and neuromuscular blockade monitors offer higher frequency choices, typically 50 and 100 Hz. These stimulators are discussed in Barthram CN, "Nerve Stimulators For Nerve Location - Are They All The Same?," Anaesthesia, Vol. 52, 1997, pp. 761-764.
  • the needles used for stimulator assisted regional anesthesia typically have a molded plastic hub that contains both a connection to plastic tubing and a wire attached to the metal needle imbedded in the hub.
  • This wire when connected to a source, supplies electrical current to the needle with appropriate output characteristics for generation of action potentials in axons.
  • Use of this equipment requires a means for holding the needle assembly, adjusting the output current, and injecting medication. This is awkward for a single user to accomplish and usually requires the presence of an assistant.
  • the commercially available nerve stimulators offer two methods of controlling the current output from the nerve stimulator instrument to a nerve stimulator needle.
  • the first method is by hand-operated dials on the face ofthe nerve stimulator instruments. In this method, it is difficult for a single operator to insert and position the needle in the patient, control the current supplied the nerve stimulator needle, and inject the medication in the patient.
  • the second method is by a foot-operated pedal connected via a cable to the nerve stimulator instrument.
  • An output source with foot-pedal control such as described in U.S. Patent No. 5,830,151 to Hadzic, necessitates a multiplicity of wires connecting pieces of equipment together.
  • any equipment that adds additional cables spread out across the floor or tables and carts represents increased hazard for stumbling and consequent injury. Also, efficiency of movement is highly prized in the operating room environment.
  • the device disclosed by Chester does not allow for one-handed operation of needle advancement and current control.
  • the needle is advanced by one hand while the current must be controlled by turning the knob 27 with the other hand, which is an extremely awkward operation for the user.
  • the nerve stimulator ofthe Chester patent restricts the size ofthe syringe upon which it may be mounted, thus, requiring the operator to change the syringe on the needle. This combination makes it very difficult to stabilize the needle within 1-2 mm of a nerve as desired for a regional block.
  • U.S. Patent 5,306,236 to Blumenfeld et al. discloses a handle 36 to which the syringe, the needle and a conductor for carrying an electrical signal are attached.
  • the control mechanism for controlling the application of current to the needle is located remotely from the needle at a stimulator device.
  • the system of Blumenfeld also does not allow for one- handed operation of both needle advancement and current control. Accordingly, the system ofthe Blumenfeld patent also provides a clumsy operation for the user.
  • needle tip depth is valuable both for medical record purposes as well as a check on needle position during the performance of a procedure. Accurate initial needle position may be obtained, but then undergo alteration by displacement during the injection portion of the procedure. Displacement may be due to inadvertent pressure applied by the operator, or the tendency of the injected fluid to force the needle back along its tissue track. The presence of visual guides on the needle itself, or a read out of needle tip depth on the nerve stimulator device, would provide feedback to the operator so as to prevent needle displacement. At present, there is no mechanism for providing such information with the currently available needles designed for use with nerve stimulators.
  • an output control needle comprising an insulated hypodermic needle having a means for fingertip control of the stimulator output current and a means of depth determination.
  • the invention will provide a means for a single operator, the anesthetist, to accurately position a needle and perform a regional anesthetic technique without need of an assistant or excessive cabling. This further reduces the costs associated with an assistant's time while maintaining operating room hazards at a minimum.
  • a nerve stimulator needle apparatus may comprise: a needle capable of carrying an electric current; a variable control mechanism which is operable to variably control the amplitude of an application of electric current to the needle; a plurality of electrical connectors connected to the variable control mechanism and the needle which allows the variable control mechanism to remotely connect to a nerve stimulation device which is operable to provide a voltage to the variable control mechanism and to provide a current pulse to the needle having an amplitude which is controlled by the variable control mechanism; and a housing which holds the variable control mechanism, the plurality of electrical connectors and the needle.
  • the needle may be an insulated hypodermic needle
  • the apparatus may further comprise: an injection tube operably connected to the needle to provide a fluid to said needle.
  • the housing may include a fluid path, and the injection tube may be connected to one end ofthe fluid path and the needle may be connected to another other end of said fluid path.
  • variable control mechanism of the needle apparatus may include a pressure sensitive switching mechanism which changes the amplitude of the current applied to the needle in relation to the amount of pressure applied to the pressure sensitive switching mechanism.
  • the housing of the needle apparatus may further include conductive traces that connect the variable control mechanism and the needle to said electrical connectors.
  • the needle unit of the needle apparatus may include an electrically resistive layer covering the needle, wherein the resistance of the resistive layer changes with the length of the resistive layer, and a conductor associated with the housing may provide a voltage to the electrically resistive layer.
  • the needle unit may further include an insulating layer between the electrically resistive layer and the needle.
  • the needle unit may further includes depth measurement marks that indicate the insertion depth ofthe needle.
  • the variable control mechanism ofthe needle apparatus may comprise a variable optical switching device.
  • the variable optical switching device may include a partially colored plate and a fiber optic cable which directs light from a light source to impinge on the partially colored plate, and direct reflected light from the partially colored plate to a sensor.
  • the partially colored plate preferably alters color or intensity component of the light impinged on it from said fiber optic cable in response to an application of pressure.
  • the variable optical switching device may include a graduated reflective plate and a fiber optic cable that directs light from a light source to impinge on the graduated reflective plate, and direct reflected light from the graduated reflective plate to a sensor.
  • the graduated reflective plate preferably alters color or intensity component of the light impinged on it from the fiber optic cable in response to an application of pressure.
  • the invention may also include a nerve stimulator apparatus comprising: a nerve stimulator device comprising: a voltage source; a controller; and a current source operable to produce an electrical current in response to said controller; and a needle unit remotely located from said nerve stimulator device and connected to said nerve stimulator device only by at least one electrical conductor, said needle unit comprising: a variable control mechanism which is operable to receive a voltage from said voltage source and to provide instructions to said controller to variably control the amplitude of said electrical current provided by said current source; a needle capable of carrying said electric current from said current source having the amplitude controlled by said variable control mechanism; and a housing which holds said variable control mechanism and said needle.
  • a nerve stimulator apparatus comprising: a nerve stimulator device comprising: a voltage source; a controller; and a current source operable to produce an electrical current in response to said controller; and a needle unit remotely located from said nerve stimulator device and connected to said nerve stimulator device only by at least one electrical conductor, said needle unit comprising: a variable
  • the variable control mechanism may include a pressure sensitive switching mechanism that changes the amplitude of the current applied to the needle in relation to the amount of pressure applied to the pressure sensitive switching mechanism.
  • the current source is preferably operable to increase or decrease current in response to the operation ofthe variable control mechanism, and the variable control mechanism is operable to increase or decrease current to the needle.
  • the current source preferably changes the amplitude of the current in response to the operation of the variable control mechanism and the variable control mechanism is operable to control the rate of change of the current.
  • the needle unit may include an electrically resistive layer covering the needle, wherein the resistance of the resistive layer changes with the length of the resistive layer, and an electrical trace from an electrical connector provides a voltage from the voltage source, so as to maintain a constant current, to the electrically resistive layer.
  • the value R a is calculated from the ratio of the voltage of a signal detected by a return electrode attached to the surface of the skin of a subject divided by the applied current ofthe resistive layer on the needle.
  • the invention further comprises a method of locating nerves may comprise the steps of: (A) inserting a needle mounted on a housing through a surface of skin of a subject; (B) activating a variable control mechanism mounted on the housing to provide a variably controlled current to the needle; (C) monitoring a detected current signal from a return electrode attached to the surface of skin of a subject using a nerve stimulator device, wherein steps A and B are performed by the same hand of an operator.
  • the method of locating nerves may further comprise the step of determining the needle insertion depth by providing a voltage to a resistive layer, completing a circuit through a return electrode on the skin surface.
  • the determination of the needle depth may comprise the steps of: continuously applying a constant current to a resistive layer on the surface of the needle; periodically applying a current pulse to the needle while applying the constant current; waiting for a period of time to elapse after applying the current pulse to the needle and determining the resistance of the resistive layer ofthe needle exposed from the surface of skin ofthe subject; and calculating the depth ofthe needle inserted in the surface of skin ofthe subject.
  • FIGS. 1 A and IB illustrate a first embodiment of stimulator needle assembly ofthe present invention
  • Figure 2 illustrates the stimulator needle assembly ofthe first embodiment in operation
  • Figures 3A-3C illustrate a second embodiment of a stimulator needle assembly ofthe present invention
  • Figure 4 illustrates the stimulator needle assembly ofthe second embodiment in operation
  • Figure 5 illustrates a modified version ofthe needle shaft ofthe second embodiment
  • Figure 6 illustrates a third embodiment of a stimulator needle assembly ofthe present invention
  • Figure 7 is a flow diagram that illustrates the determination ofthe needle depth
  • Figure 8 illustrates a fourth embodiment of a stimulator needle ofthe present invention.
  • Figure 9 illustrates the operation ofthe variable control mechanism of the fourth embodiment ofthe present invention.
  • a preferred embodiment ofthe present invention comprises a nerve stimulator function that allows control ofthe current output through a fingertip control on the stimulating needle.
  • a preferred embodiment ofthe needle assembly ofthe present invention is illustrated in FIG. 1 A (front view) and FIG. IB (side view).
  • a needle assembly consists of a housing unit 102.
  • the housing unit may be made of any suitable material such as molded plastic.
  • the housing unit 102 preferably contains a plurality of electrical pin connectors 103, 104 and 105 that electrically connect the housing unit 102 to an external nerve stimulator device or a plurality of external devices.
  • Electrical traces 139, 140, and 143 are preferably embedded within the housing unit 102 and are electrically connected to a corresponding electrical pin connector.
  • the housing unit 102 also preferably contains an embedded fluid path 110 through which fluid from a tube 109 may flow to a needle 107.
  • the tube 109 may be any tube suitable for carrying fluids such as a plastic injection tube.
  • the tube 109 may be formed within the housing unit 102 or may mate with the housing unit 102 via known techniques of mating tubes.
  • Needle 107 is preferably inserted into a cavity (not shown) in the housing unit 102 so that it mates with the embedded fluid path 110. Needle 107 may be detachable from housing 102 or may be permanently affixed to housing 102.
  • the hypodermic needle preferably consists of stainless steel, and is preferably coated with an insulation layer 108, although a needle without the insulation layer may be used but may provide less efficient current transfer to the nerve.
  • the needle tip is preferably not coated with the insulation layer and the needle tip may be of any type of bevel, such as a short or a long bevel.
  • the insulation layer 108 is preferably a biocompatible insulation layer and preferably comprised of Teflon, polyethylene, PNC, polypropylene, or any other suitable material.
  • a variable control mechanism 101 for variably controlling the current applied to needle 107 may include any type of finger actionable switch, such as a rocker switch, pressure switch, slider switch or any other known finger actionable switch, attached to the housing unit 102.
  • a voltage may be applied from a voltage source 180 to the variable control mechanism 101 via an electrical pin connector 103 and electrical trace 140 in the housing unit 102 and reduced or increased depending on the operation ofthe variable control mechanism 101.
  • the output voltage on the variable control mechanism 101 is directed to a control device 181, via a second electrical pin connector 104, for processing and determining the output current to be delivered from a current source 182 via the third electrical pin connector 105 to the embedded hypodermic needle 107.
  • the current provided by the current source 182 is preferably in the form of a pulse train as known in the art.
  • FIG. 2 illustrates the operation ofthe stimulator needle assembly.
  • a syringe 132 is connected to housing unit 102 via tube 109.
  • a hypodermic needle 107 is also attached to the housing unit 102, and advanced through the skin surface 136.
  • a nerve stimulator device 131 is electrically connected to electrical pin connectors 103-105 via electrical cables 126, 142, and 122 through electrical pin connectors 129, 130 and 127, respectively.
  • the source 180, control device 181 and the current source 182 are contained in the nerve stimulator 131.
  • the nerve stimulator 131 is activated and controlled by the variable control mechanism 101 via the current output control cable 142 attached to the nerve stimulator 131 by electrical pin connector 130.
  • the output current is supplied through electrical pin connector 127 via an electrical cable 122 to electrical pin connector 105 on the housing unit 102.
  • Voltage is output through electrical pin connector 129 via electrical cable 126 to electrical pin connector 103 on the housing unit 102 for output current control.
  • the electrical return electrode 135 bears a connector 134 that attaches via an electrical cable 123 to an electrical pin connector 128 on the nerve stimulator 131.
  • the return electrode 135 is typically a silver-silver chloride electrocardiographic electrode.
  • the operator is able to determine the proximity ofthe needle tip to the nerve by observation of a visible twitch stimulated in the muscle supplied by the target nerve.
  • a nerve stimulator operation current is supplied to the hypodermic needle 107 at a level of 1-2 mA and the needle advanced until muscle twitch is achieved.
  • the amplitude ofthe current output may be gradually decreased by the use ofthe variable control mechanism 101 until twitch is observed at less than 0.5 mA as shown on display 141.
  • the needle tip position is an appropriate distance from the nerve, e.g., 1-2 mm at a current output of less than 0.5 mA, the operator injects the solution in the syringe.
  • FIG. 3 A illustrates a frontal view ofthe second embodiment
  • Figure 3B illustrates a side view
  • Figure 3C illustrates a cross sectional view ofthe needle ofthe second embodiment.
  • the needle 107 shown in Figures 3 A, 3B and 3C is able to determine depth of hypodermic needle penetration beneath the skin by using a linear resistance coating 106 connected to the voltage source 180 via an electrical pin connector 103 and an electrical trace 111.
  • the preferred material for this linear resistance coating is a conductive polymer coating such as a polyaniline (OrmeconTM), although any suitable linear resistive material may be used, such as a normally nonconductive polymer that has been doped with a conductive material.
  • the nonconductive polymer silastic can be doped with carbon to become conductive.
  • the linear resistance coating 106 is separated from the stainless steel hypodermic needle 107 by an insulation layer 108, shown as a hatched area surrounding the needle in the figures.
  • the needle of the second embodiment also may be used with the nerve stimulator 131' shown in Figure 4.
  • the needle of the second embodiment locates a nerve in the same manner as described in the first embodiment, except that the needle of the second embodiment has the ability to determine the insertion depth of the needle in the skin of a subject.
  • nerve stimulator 131' in Figure 4 contains a constant current voltage source 190.
  • Existing nerve stimulators are designed to deliver constant current pulses for nerve stimulation purposes. These devices do not provide constant current (a constant non pulsed current). However, one of skill in the art is able to readily design a constant current source 190, and the circuit design may be analogous to that for producing the constant current pulse for stimulation.
  • the nerve stimulator 131' described herein preferably contains two separate current sources, one of which, the constant current source 182, is adjustable by the user for stimulation pulse generation, i.e. pulse current i.
  • the constant current voltage source 190 is not adjustable by the user and provides a constant current (I) to the linear resistance coating 106.
  • the return electrode 135 for depth determination by resistance measurement is located remotely on the skin surface and is the same return electrode as that for the current output of the nerve stimulator 131.
  • a voltage signal from the constant current voltage source 190 is applied to the linear resistance coating 106 via electrical pin connector 103 and electrical trace 111.
  • the circuit is completed through the linear resistance coating 106 as it penetrates the skin, thus the return electrode 135 detects the signal and provides the detected signal to the nerve stimulator 131' via electrical cable 123 and electrical pin connector 128.
  • the nerve stimulator 131' detects the voltage ofthe detected signal using a voltmeter 145.
  • the resistance of the linear resistance coating 106 is constant per unit length and significantly higher than that of tissue, which is on the order of 1.0 megaohm per mm.
  • Tissue impedance is typically in the range of 0.1-1.0 kilohms. Since the tissue impedance is less than the resistance of any portion of the needle by orders of magnitude, the resistance ofthe circuit is approximately that of the needle coating alone.
  • the total resistance (R t ) of the needle linear resistance coating 106 is the product of the resistance per unit length ( ⁇ ) and the length of the needle (L t ).
  • R t may be represented as the sum ofthe length protruding above the skin (L a ) 137 multiplied by ⁇ and of the length beneath the skin (L b ) 138 multiplied by ⁇ L, as given in equation 1.
  • the return electrode 135 is used for both stimulator current control and for needle depth determination through the measurement of resistance.
  • Figure 7 illustrates an exemplary method of determining the depth ofthe needle which is preferably carried out by a microprocessor in the nerve stimulator 131'.
  • the nerve stimulator 131' illustrated in Figure 4 provides a constant DC current I, by way of a variable voltage, to the linear resistive coating 106 on the nerve stimulator needle 107 via electrical pin connector 103 and electrical trace 111.
  • the nerve stimulator 131' provides a periodic current pulse i to the needle 107, having its amplitude controlled by variable control mechanism 101, via electrical trace 139 (step S2).
  • the constant current I is preferably continuously provided, and is not interrupted by the periodic current pulse i provided to the needle 107.
  • the resistance R a is determined from the DC current I after the current pulse i decays in the skin ofthe subject, i.e. during the portion of the interpulse interval when no current pulse from the stimulator function is occurring.
  • the current pulse is less than or equal to 5 msec in duration and, since the frequency of the pulse signal provided to the nerve stimulator needle 107 is a maximum of 5 Hz, the interpulse duration is 45 msec.
  • a tissue time constant may be calculated from the product of R and C.
  • tissue time constants 5RC
  • t may set to a value greater than or equal to 5 msec.
  • the microprocessor waits for the time t to elapse since the end of the current pulse i (No in step 6). Once the time t has elapsed (Yes in step 6), the measured voltage from return electrode 135 via voltmeter 145 is used to calculate R a (step S8).
  • the needle depth Lb is then calculate in step S10 according to equation 2, and displayed in step SI 2.
  • the calculated value of L b may then be visually displayed on display 141.
  • the calculated value L may also be audibly displayed and/or may be printed by a printing device attached either directly or indirectly to nerve stimulator 131'.
  • Figure 5 illustrates a cross section of the needle that may be used with the second embodiment.
  • needle 107 is coated with insulation layer 108 that is coated with linear resistive coating 106 as in the second embodiment.
  • indelible marks 113 preferably comprised of biocompatible material, may be included on the resistance coating to provide visual reference of the depth to which the tip of the needle has been inserted. These depth measuring mechanisms allow accurate recording of the needle depth at which an injection was performed and allow for accurate maintenance of needle position during the injection procedure as well as for a period of time after injection when subsequent stimulation attempts are undertaken by the anesthetist. It will be appreciated that the indelible marks 113 may be applied to the insulation layer 108, in the absence of the resistive coating 106, to provide a visual depth reference.
  • a third embodiment is shown in Figure 6.
  • a strip of resistance material 112 such as a tantalum wire, or ceramic strip resistance, may be substituted for the conductive polymer.
  • This material preferably runs the length of the needle shaft and is separated from the hypodermic needle 107 by the insulation layer 108. This material provides the same linear resistance characteristics as the conductive polymer for use in depth determination, and operates in the same manner as described in embodiment 2.
  • variable control mechanism 101" may be an optical device controlling the current output by a mixture of light wavelengths determined by the degree to which the variable control mechanism 101 is depressed.
  • An example of such a control device is the ColdswitchTM.
  • the electrical pin connector 104 is replaced by a fiber optic cable 124.
  • the variable control mechanism 101" is preferably connected to a nerve stimulator 131 or 131' that senses the direction of change mediated through the variable control mechanism 101", as well as the rate of change of switching events.
  • FIG. 9 The operation of this embodiment is illustrated in Figure 9.
  • light from an LED source 116 contained in a photonic sensor and control 115 is directed via fiber optic cable 124 to an optical control mechanism 114, contained in the variable control mechanism 101".
  • Optical control mechanism 114 contains a reflective plate 118 that is partially colored, such as by a color coating, or is a graduated reflective plate that has different reflective properties along the length of the plate.
  • Optical control mechanism 114 also contains a pivot 119 upon which reflective plate 118 may pivot upon the application of pressure from an operator. The light from LED source 116 is reflected off of reflective plate 118 and transmitted back to the photonic sensor 117 via fiber optic cable 124.
  • the photonic sensor and control 115 detects the direction of change of variable control mechanism 101", mediated through the optical control mechanism 114, as well as the rate of change of switching events, by the reflected color or intensity mixing. Color or intensity mixing is accomplished by a reflective plate 118. When the reflective plate 118 is rocked by finger pressure on its pivot 119, the white incident light emitted from the fiber optic cable 124 is reflected back with altered color or intensity components. The intensity or color is detected by the photonic sensor 117, electronically processed by the microprocessor 120 and converted to a corresponding current output via the constant current pulse generator 121.
  • commands to the nerve stimulator can be controlled through switching events, including, but not limited to sequential taps, sudden release or sudden depression.

Abstract

An improved nerve stimulator needle (107) which allows for improved ease of use and efficacy in the performance of targeted drug delivery to nerve. A variable control mechanism (101) is contained in a housing (102) to which a needle (107) is attached and several electrical conductors are attached. The housing (102) contains an embedded fluid path (110) through which a syringe (132) is attached to the needle (107). The variable control mechanism (101) and the housing (102) allows for positioning the needle (107) and applying current to the needle (107) with the same hand. The needle (107) may also contain a linear resistive coating (106), which enables thedetermination of the depth of the needlel (107) by determining the resistance of the length of theneedle (107) above the skin surface (136) of a patient. Another embodiment of the needle (107) may include an optical variable control mechanism (114).

Description

NERVE STIMULATOR OUTPUT CONTROL NEEDLE WITH DEPTH DETERMINATION CAPABILITY AND
METHOD OF USE
Field ofthe Invention
This invention relates to a nerve-stimulating needle with fingertip control of stimulator current output and visual as well as electrical depth determination ability.
BACKGROUND OF THE INVENTION
Anesthesiologists commonly use nerve stimulators and insulated needles for the purpose of locating peripheral nerves, or nerve plexuses, for the performance of regional anesthesia procedures. This procedure is discussed in Nloka JD et al., "A National Survey On Practice Patterns In The Use Of Peripheral Nerve Stimulators In Regional Anesthesia," The Internet Journal of Anesthesiology, Vol. 3, No. 4, 1999. In addition to targeting local anesthetic delivery for regional anesthesia, the use of nerve stimulators reduces the potential for nerve injury since direct contact with the nerve is not required for performance ofthe anesthetic. This is in contrast to the alternative method of seeking paresthesias to confirm needle position. Paresthesias are provoked by directly disturbing the nerve. If such needle to nerve contact can be avoided, direct needle trauma should be reduced. The available nerve stimulators have differing output characteristics.
The shape of the pulse is typically square or nearly so. The pulse widths vary from 40 microseconds (μs) to 2 milliseconds (ms). Frequency selections for these stimulators range from 1.0 Hertz (Hz) to 100 Hz, in step gradations rather than continuously. Stimulators that are manufactured specifically for regional anesthesia applications typically do not have frequency options greater than 5 Hz. The stimulators that serve as both nerve stimulators and neuromuscular blockade monitors offer higher frequency choices, typically 50 and 100 Hz. These stimulators are discussed in Barthram CN, "Nerve Stimulators For Nerve Location - Are They All The Same?," Anaesthesia, Vol. 52, 1997, pp. 761-764.
The needles used for stimulator assisted regional anesthesia typically have a molded plastic hub that contains both a connection to plastic tubing and a wire attached to the metal needle imbedded in the hub. This wire, when connected to a source, supplies electrical current to the needle with appropriate output characteristics for generation of action potentials in axons. Use of this equipment requires a means for holding the needle assembly, adjusting the output current, and injecting medication. This is awkward for a single user to accomplish and usually requires the presence of an assistant.
The commercially available nerve stimulators offer two methods of controlling the current output from the nerve stimulator instrument to a nerve stimulator needle. The first method is by hand-operated dials on the face ofthe nerve stimulator instruments. In this method, it is difficult for a single operator to insert and position the needle in the patient, control the current supplied the nerve stimulator needle, and inject the medication in the patient.
The second method is by a foot-operated pedal connected via a cable to the nerve stimulator instrument. An output source with foot-pedal control, such as described in U.S. Patent No. 5,830,151 to Hadzic, necessitates a multiplicity of wires connecting pieces of equipment together. In the environment of an operating room where a multiplicity of electrical cables already exists, any equipment that adds additional cables spread out across the floor or tables and carts represents increased hazard for stumbling and consequent injury. Also, efficiency of movement is highly prized in the operating room environment.
When an anesthetic procedure is completed, the operating room personnel move rapidly to begin the surgical positioning and prepping. Often, the anesthesiologist is in the position of gathering up equipment used for a procedure, and either disposing of it or placing it on a cart for subsequent storage. Tangles of cables and wires complicate this process and have a tendency to increase the clutter surrounding anesthesia machines and carts. U.S. Patent 4,515,168 to Chester et al. discloses to clamp a nerve stimulator and locating device onto a syringe. As the entire nerve stimulator device is clamped onto the syringe, the unit is a long and clumsy assembly, which is difficult to maneuver. Moreover, the device disclosed by Chester does not allow for one-handed operation of needle advancement and current control. Particularly, the needle is advanced by one hand while the current must be controlled by turning the knob 27 with the other hand, which is an extremely awkward operation for the user. Additionally, the nerve stimulator ofthe Chester patent restricts the size ofthe syringe upon which it may be mounted, thus, requiring the operator to change the syringe on the needle. This combination makes it very difficult to stabilize the needle within 1-2 mm of a nerve as desired for a regional block.
U.S. Patent 5,306,236 to Blumenfeld et al. discloses a handle 36 to which the syringe, the needle and a conductor for carrying an electrical signal are attached. The control mechanism for controlling the application of current to the needle is located remotely from the needle at a stimulator device. Like the Chester patent, the system of Blumenfeld also does not allow for one- handed operation of both needle advancement and current control. Accordingly, the system ofthe Blumenfeld patent also provides a clumsy operation for the user.
It is frequently useful, during and after the performance of a regional anesthetic procedure, to know the depth at which the nerve structure was located. The consideration of needle tip depth is valuable both for medical record purposes as well as a check on needle position during the performance of a procedure. Accurate initial needle position may be obtained, but then undergo alteration by displacement during the injection portion of the procedure. Displacement may be due to inadvertent pressure applied by the operator, or the tendency of the injected fluid to force the needle back along its tissue track. The presence of visual guides on the needle itself, or a read out of needle tip depth on the nerve stimulator device, would provide feedback to the operator so as to prevent needle displacement. At present, there is no mechanism for providing such information with the currently available needles designed for use with nerve stimulators.
SUMMARY OF THE INVENTION In accordance with the present invention, an output control needle comprising an insulated hypodermic needle having a means for fingertip control of the stimulator output current and a means of depth determination. The invention will provide a means for a single operator, the anesthetist, to accurately position a needle and perform a regional anesthetic technique without need of an assistant or excessive cabling. This further reduces the costs associated with an assistant's time while maintaining operating room hazards at a minimum.
It is an object of the present invention to provide a nerve stimulator needle with fingertip control of output current, which avoids the need for an assistant or foot pedal to adjust the output source during the performance of a regional anesthetic procedure.
It is an object of the present invention to provide a nerve stimulator needle with fingertip control of output current allowing the second hand to perform medication injection. It is an object of the present invention to provide a nerve stimulator needle with a means of electronically measuring the depth at which a nerve structure is encountered.
It is an object of the present invention to provide a nerve stimulator needle with a means of visually measuring the depth at which a nerve structure is encountered.
In the present invention a nerve stimulator needle apparatus may comprise: a needle capable of carrying an electric current; a variable control mechanism which is operable to variably control the amplitude of an application of electric current to the needle; a plurality of electrical connectors connected to the variable control mechanism and the needle which allows the variable control mechanism to remotely connect to a nerve stimulation device which is operable to provide a voltage to the variable control mechanism and to provide a current pulse to the needle having an amplitude which is controlled by the variable control mechanism; and a housing which holds the variable control mechanism, the plurality of electrical connectors and the needle.
The needle may be an insulated hypodermic needle, and the apparatus may further comprise: an injection tube operably connected to the needle to provide a fluid to said needle. The housing may include a fluid path, and the injection tube may be connected to one end ofthe fluid path and the needle may be connected to another other end of said fluid path.
The variable control mechanism of the needle apparatus may include a pressure sensitive switching mechanism which changes the amplitude of the current applied to the needle in relation to the amount of pressure applied to the pressure sensitive switching mechanism.
The housing of the needle apparatus may further include conductive traces that connect the variable control mechanism and the needle to said electrical connectors.
The needle unit of the needle apparatus may include an electrically resistive layer covering the needle, wherein the resistance of the resistive layer changes with the length of the resistive layer, and a conductor associated with the housing may provide a voltage to the electrically resistive layer. The needle unit may further include an insulating layer between the electrically resistive layer and the needle.
The needle unit may further includes depth measurement marks that indicate the insertion depth ofthe needle.
The variable control mechanism ofthe needle apparatus may comprise a variable optical switching device. The variable optical switching device may include a partially colored plate and a fiber optic cable which directs light from a light source to impinge on the partially colored plate, and direct reflected light from the partially colored plate to a sensor. The partially colored plate preferably alters color or intensity component of the light impinged on it from said fiber optic cable in response to an application of pressure.
The variable optical switching device may include a graduated reflective plate and a fiber optic cable that directs light from a light source to impinge on the graduated reflective plate, and direct reflected light from the graduated reflective plate to a sensor. The graduated reflective plate preferably alters color or intensity component of the light impinged on it from the fiber optic cable in response to an application of pressure. The invention may also include a nerve stimulator apparatus comprising: a nerve stimulator device comprising: a voltage source; a controller; and a current source operable to produce an electrical current in response to said controller; and a needle unit remotely located from said nerve stimulator device and connected to said nerve stimulator device only by at least one electrical conductor, said needle unit comprising: a variable control mechanism which is operable to receive a voltage from said voltage source and to provide instructions to said controller to variably control the amplitude of said electrical current provided by said current source; a needle capable of carrying said electric current from said current source having the amplitude controlled by said variable control mechanism; and a housing which holds said variable control mechanism and said needle.
The variable control mechanism may include a pressure sensitive switching mechanism that changes the amplitude of the current applied to the needle in relation to the amount of pressure applied to the pressure sensitive switching mechanism. The current source is preferably operable to increase or decrease current in response to the operation ofthe variable control mechanism, and the variable control mechanism is operable to increase or decrease current to the needle. The current source preferably changes the amplitude of the current in response to the operation of the variable control mechanism and the variable control mechanism is operable to control the rate of change of the current.
The needle unit may include an electrically resistive layer covering the needle, wherein the resistance of the resistive layer changes with the length of the resistive layer, and an electrical trace from an electrical connector provides a voltage from the voltage source, so as to maintain a constant current, to the electrically resistive layer. The microprocessor preferably determines the insertion depth ofthe needle according to the equation: Lb= (Rt- Ra) / rL where Ra is the resistance of the portion of the needle protruding above a skin surface of a subject; Rt is the resistance ofthe total length ofthe needle; ΓL is the resistance per unit length of the needle; and Lb is the insertion depth of the needle. Wherein the value Ra is calculated from the ratio of the voltage of a signal detected by a return electrode attached to the surface of the skin of a subject divided by the applied current ofthe resistive layer on the needle.
The invention further comprises a method of locating nerves may comprise the steps of: (A) inserting a needle mounted on a housing through a surface of skin of a subject; (B) activating a variable control mechanism mounted on the housing to provide a variably controlled current to the needle; (C) monitoring a detected current signal from a return electrode attached to the surface of skin of a subject using a nerve stimulator device, wherein steps A and B are performed by the same hand of an operator. The method of locating nerves may further comprise the step of determining the needle insertion depth by providing a voltage to a resistive layer, completing a circuit through a return electrode on the skin surface.
The step of determining the needle insertion depth is preferably performed according to the equation: Lb = (Rt- Ra) / rL where Ra is the resistance of the portion of the needle protruding above a skin surface of a subject; Rt is the resistance ofthe total length ofthe needle; ΓL is the resistance per unit length of the needle; and L is the insertion depth of the needle. The determination of the needle depth may comprise the steps of: continuously applying a constant current to a resistive layer on the surface of the needle; periodically applying a current pulse to the needle while applying the constant current; waiting for a period of time to elapse after applying the current pulse to the needle and determining the resistance of the resistive layer ofthe needle exposed from the surface of skin ofthe subject; and calculating the depth ofthe needle inserted in the surface of skin ofthe subject. BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying drawings, which are incorporated in and form a part ofthe specification, illustrate the various embodiments ofthe present invention, and together with the description, serve to explain the principles ofthe invention. In the drawings:
Figures 1 A and IB illustrate a first embodiment of stimulator needle assembly ofthe present invention;
Figure 2 illustrates the stimulator needle assembly ofthe first embodiment in operation; Figures 3A-3C illustrate a second embodiment of a stimulator needle assembly ofthe present invention;
Figure 4 illustrates the stimulator needle assembly ofthe second embodiment in operation;
Figure 5 illustrates a modified version ofthe needle shaft ofthe second embodiment;
Figure 6 illustrates a third embodiment of a stimulator needle assembly ofthe present invention;
Figure 7 is a flow diagram that illustrates the determination ofthe needle depth; Figure 8 illustrates a fourth embodiment of a stimulator needle ofthe present invention; and
Figure 9 illustrates the operation ofthe variable control mechanism of the fourth embodiment ofthe present invention.
DETAILED DESCRIPTION OF THE INVENTION
Reference will now be made in detail to the present preferred embodiment ofthe invention, an example of which is illustrated in the accompanying drawings.
A preferred embodiment ofthe present invention comprises a nerve stimulator function that allows control ofthe current output through a fingertip control on the stimulating needle. A preferred embodiment ofthe needle assembly ofthe present invention is illustrated in FIG. 1 A (front view) and FIG. IB (side view). A needle assembly consists of a housing unit 102. The housing unit may be made of any suitable material such as molded plastic. The housing unit 102 preferably contains a plurality of electrical pin connectors 103, 104 and 105 that electrically connect the housing unit 102 to an external nerve stimulator device or a plurality of external devices. Electrical traces 139, 140, and 143 are preferably embedded within the housing unit 102 and are electrically connected to a corresponding electrical pin connector.
The housing unit 102 also preferably contains an embedded fluid path 110 through which fluid from a tube 109 may flow to a needle 107. The tube 109 may be any tube suitable for carrying fluids such as a plastic injection tube. The tube 109 may be formed within the housing unit 102 or may mate with the housing unit 102 via known techniques of mating tubes. Needle 107 is preferably inserted into a cavity (not shown) in the housing unit 102 so that it mates with the embedded fluid path 110. Needle 107 may be detachable from housing 102 or may be permanently affixed to housing 102. Those of skill in the art will appreciate that the tube 109 and the needle 107 should be attached to the embedded fluid path 110 according to techniques known in the art in a manner that avoids leakage ofthe fluid and also avoids contamination ofthe fluid. The hypodermic needle preferably consists of stainless steel, and is preferably coated with an insulation layer 108, although a needle without the insulation layer may be used but may provide less efficient current transfer to the nerve. The needle tip is preferably not coated with the insulation layer and the needle tip may be of any type of bevel, such as a short or a long bevel. The insulation layer 108 is preferably a biocompatible insulation layer and preferably comprised of Teflon, polyethylene, PNC, polypropylene, or any other suitable material.
A variable control mechanism 101 for variably controlling the current applied to needle 107 may include any type of finger actionable switch, such as a rocker switch, pressure switch, slider switch or any other known finger actionable switch, attached to the housing unit 102. A voltage may be applied from a voltage source 180 to the variable control mechanism 101 via an electrical pin connector 103 and electrical trace 140 in the housing unit 102 and reduced or increased depending on the operation ofthe variable control mechanism 101. The output voltage on the variable control mechanism 101 is directed to a control device 181, via a second electrical pin connector 104, for processing and determining the output current to be delivered from a current source 182 via the third electrical pin connector 105 to the embedded hypodermic needle 107. The current provided by the current source 182 is preferably in the form of a pulse train as known in the art.
Figure 2 illustrates the operation ofthe stimulator needle assembly. As shown in Figure 2, a syringe 132 is connected to housing unit 102 via tube 109. A hypodermic needle 107 is also attached to the housing unit 102, and advanced through the skin surface 136. A nerve stimulator device 131 is electrically connected to electrical pin connectors 103-105 via electrical cables 126, 142, and 122 through electrical pin connectors 129, 130 and 127, respectively. The source 180, control device 181 and the current source 182 are contained in the nerve stimulator 131.
As the needle is advanced through the skin surface 136, the nerve stimulator 131 is activated and controlled by the variable control mechanism 101 via the current output control cable 142 attached to the nerve stimulator 131 by electrical pin connector 130. The output current is supplied through electrical pin connector 127 via an electrical cable 122 to electrical pin connector 105 on the housing unit 102. Voltage is output through electrical pin connector 129 via electrical cable 126 to electrical pin connector 103 on the housing unit 102 for output current control. The electrical return electrode 135 bears a connector 134 that attaches via an electrical cable 123 to an electrical pin connector 128 on the nerve stimulator 131. The return electrode 135 is typically a silver-silver chloride electrocardiographic electrode. The operator is able to determine the proximity ofthe needle tip to the nerve by observation of a visible twitch stimulated in the muscle supplied by the target nerve. In a nerve stimulator operation, current is supplied to the hypodermic needle 107 at a level of 1-2 mA and the needle advanced until muscle twitch is achieved. By following appropriate muscle twitches, the amplitude ofthe current output may be gradually decreased by the use ofthe variable control mechanism 101 until twitch is observed at less than 0.5 mA as shown on display 141. When the needle tip position is an appropriate distance from the nerve, e.g., 1-2 mm at a current output of less than 0.5 mA, the operator injects the solution in the syringe. This process, using a nerve stimulator needle ofthe prior art, is generally described in U.S. Patent 5,830,151 to Hadzic et al. A second embodiment of he present invention is illustrated in Figures 3 A, 3B and 3C. The second embodiment is similar to the first embodiment except that the second embodiment includes the ability to determine the depth ofthe needle inserted in the skin. The same components are numbered with the same reference numbers. Figure 3 A illustrates a frontal view ofthe second embodiment, Figure 3B illustrates a side view, and Figure 3C illustrates a cross sectional view ofthe needle ofthe second embodiment.
The needle 107 shown in Figures 3 A, 3B and 3C is able to determine depth of hypodermic needle penetration beneath the skin by using a linear resistance coating 106 connected to the voltage source 180 via an electrical pin connector 103 and an electrical trace 111. The preferred material for this linear resistance coating is a conductive polymer coating such as a polyaniline (Ormecon™), although any suitable linear resistive material may be used, such as a normally nonconductive polymer that has been doped with a conductive material. For example, the nonconductive polymer silastic can be doped with carbon to become conductive. By controlling the amount of dopant, the resistance of the polymer may be adjusted to suitable levels. The linear resistance coating 106 is separated from the stainless steel hypodermic needle 107 by an insulation layer 108, shown as a hatched area surrounding the needle in the figures.
The needle of the second embodiment also may be used with the nerve stimulator 131' shown in Figure 4. The needle of the second embodiment locates a nerve in the same manner as described in the first embodiment, except that the needle of the second embodiment has the ability to determine the insertion depth of the needle in the skin of a subject. For this reason, nerve stimulator 131' in Figure 4 contains a constant current voltage source 190. Existing nerve stimulators are designed to deliver constant current pulses for nerve stimulation purposes. These devices do not provide constant current (a constant non pulsed current). However, one of skill in the art is able to readily design a constant current source 190, and the circuit design may be analogous to that for producing the constant current pulse for stimulation. The nerve stimulator 131' described herein preferably contains two separate current sources, one of which, the constant current source 182, is adjustable by the user for stimulation pulse generation, i.e. pulse current i. The other of which, the constant current voltage source 190, is not adjustable by the user and provides a constant current (I) to the linear resistance coating 106.
By way of example, as shown in Figure 4, the return electrode 135 for depth determination by resistance measurement is located remotely on the skin surface and is the same return electrode as that for the current output of the nerve stimulator 131. In operation, a voltage signal from the constant current voltage source 190 is applied to the linear resistance coating 106 via electrical pin connector 103 and electrical trace 111. The circuit is completed through the linear resistance coating 106 as it penetrates the skin, thus the return electrode 135 detects the signal and provides the detected signal to the nerve stimulator 131' via electrical cable 123 and electrical pin connector 128. The nerve stimulator 131' detects the voltage ofthe detected signal using a voltmeter 145.
The resistance of the linear resistance coating 106 is constant per unit length and significantly higher than that of tissue, which is on the order of 1.0 megaohm per mm. Tissue impedance is typically in the range of 0.1-1.0 kilohms. Since the tissue impedance is less than the resistance of any portion of the needle by orders of magnitude, the resistance ofthe circuit is approximately that of the needle coating alone. The total resistance (Rt) of the needle linear resistance coating 106 is the product of the resistance per unit length (Γ ) and the length of the needle (Lt). As the needle is advanced through the skin, Rt may be represented as the sum ofthe length protruding above the skin (La) 137 multiplied by Γ and of the length beneath the skin (Lb) 138 multiplied by ΓL, as given in equation 1. Eq. 1 Rt= rL x Lt = (r x La) + (rL x Lb)
Therefore, since the resistance determined by the nerve stimulator 131' in this circuit is directly related to the length ofthe coating that protrudes above the skin surface (Ra = ΓL X La), the length of the needle below the skin surface may be determined by equation 2.
Eq. 2 Lb = (Rt- Ra) / rL
where Ra is the resistance ofthe portion ofthe needle protruding above the skin. Since Rt and ΓL are known and Ra is calculated directly from the ratio of the measured voltage to the applied current (Ohm's Law: V=IR), Lb may be calculated. If the needle is inserted to the point that the housing unit 102 contacts the skin surface, La = 0, the measured resistance is that of the tissue alone, and thus Lb = Lt in that situation.
The return electrode 135 is used for both stimulator current control and for needle depth determination through the measurement of resistance. Figure 7 illustrates an exemplary method of determining the depth ofthe needle which is preferably carried out by a microprocessor in the nerve stimulator 131'. As shown in step SO, the nerve stimulator 131' illustrated in Figure 4 provides a constant DC current I, by way of a variable voltage, to the linear resistive coating 106 on the nerve stimulator needle 107 via electrical pin connector 103 and electrical trace 111. The nerve stimulator 131' provides a periodic current pulse i to the needle 107, having its amplitude controlled by variable control mechanism 101, via electrical trace 139 (step S2). The constant current I is preferably continuously provided, and is not interrupted by the periodic current pulse i provided to the needle 107. The resistance Ra is determined from the DC current I after the current pulse i decays in the skin ofthe subject, i.e. during the portion of the interpulse interval when no current pulse from the stimulator function is occurring. The resistance measurement cannot occur early in the interpulse interval due to capacitive functions of the skin which result in a discharge voltage according to the relationship V = V; x e^~ C), where V is the observed voltage, Nj is the applied voltage ofthe current pulse i on needle 107, t is the elapsed time, and RC is the product of the resistance and the capacitance ofthe skin. Consequently, the resistance measurements for depth determination are collected in a timed fashion, rather than continuously. For example, in the preferred embodiment, the current pulse is less than or equal to 5 msec in duration and, since the frequency of the pulse signal provided to the nerve stimulator needle 107 is a maximum of 5 Hz, the interpulse duration is 45 msec. In step S4, the microprocessor determines the decay time t ofthe current pulse in the skin ofthe subject as t = 5RC. Particularly, for a circuit containing a parallel resistance (R) and capacitance (C), such as biological tissue, a tissue time constant may be calculated from the product of R and C. When subjected to a current pulse, the capacitive element of such a circuit charges over a defined time interval. On termination of the current pulse, this capacitive element discharges over a characteristic time interval, which follows an exponential decay curve, which takes about five tissue time constants (5RC) to reach 99% of the final value. This is described in more detail by Νunn (Νunn JF, Applied Respiratory Physiology, Butterworths, London, 1977, pg. 464-469) and Horowitz and Hill (Horowitz P and Hill W, The Art of Electronics, Cambridge University Press, Cambridge, MA, 1986, pg.20 - 21). Since tissue time constants are in the range of 1 msec or less, allowing greater than 5 msec to pass following the termination of the stimulating pulse provides adequate time for the measured voltage to approximate baseline values of the voltage applied to the resistive layer. Alternatively, t may set to a value greater than or equal to 5 msec. At step S6, the microprocessor waits for the time t to elapse since the end of the current pulse i (No in step 6). Once the time t has elapsed (Yes in step 6), the measured voltage from return electrode 135 via voltmeter 145 is used to calculate Ra (step S8). The needle depth Lb is then calculate in step S10 according to equation 2, and displayed in step SI 2. The calculated value of Lb may then be visually displayed on display 141. Those of skill in the art will appreciate that the calculated value L may also be audibly displayed and/or may be printed by a printing device attached either directly or indirectly to nerve stimulator 131'.
Figure 5 illustrates a cross section of the needle that may be used with the second embodiment. As illustrated in Figure 5, needle 107 is coated with insulation layer 108 that is coated with linear resistive coating 106 as in the second embodiment. In Figure 5, indelible marks 113, preferably comprised of biocompatible material, may be included on the resistance coating to provide visual reference of the depth to which the tip of the needle has been inserted. These depth measuring mechanisms allow accurate recording of the needle depth at which an injection was performed and allow for accurate maintenance of needle position during the injection procedure as well as for a period of time after injection when subsequent stimulation attempts are undertaken by the anesthetist. It will be appreciated that the indelible marks 113 may be applied to the insulation layer 108, in the absence of the resistive coating 106, to provide a visual depth reference.
A third embodiment is shown in Figure 6. In this embodiment, a strip of resistance material 112, such as a tantalum wire, or ceramic strip resistance, may be substituted for the conductive polymer. This material preferably runs the length of the needle shaft and is separated from the hypodermic needle 107 by the insulation layer 108. This material provides the same linear resistance characteristics as the conductive polymer for use in depth determination, and operates in the same manner as described in embodiment 2.
A fourth embodiment of the invention is illustrated in Figures 8 and 9. In this embodiment, the variable control mechanism 101" may be an optical device controlling the current output by a mixture of light wavelengths determined by the degree to which the variable control mechanism 101 is depressed. An example of such a control device is the Coldswitch™. In the case of optical control, the electrical pin connector 104 is replaced by a fiber optic cable 124. The same elements in this embodiment as in the previous embodiments are numbered the same. Just as in the first embodiment, the variable control mechanism 101" is preferably connected to a nerve stimulator 131 or 131' that senses the direction of change mediated through the variable control mechanism 101", as well as the rate of change of switching events.
The operation of this embodiment is illustrated in Figure 9. In Figure 9, light from an LED source 116 contained in a photonic sensor and control 115 is directed via fiber optic cable 124 to an optical control mechanism 114, contained in the variable control mechanism 101". Optical control mechanism 114 contains a reflective plate 118 that is partially colored, such as by a color coating, or is a graduated reflective plate that has different reflective properties along the length of the plate. Optical control mechanism 114 also contains a pivot 119 upon which reflective plate 118 may pivot upon the application of pressure from an operator. The light from LED source 116 is reflected off of reflective plate 118 and transmitted back to the photonic sensor 117 via fiber optic cable 124. The photonic sensor and control 115 detects the direction of change of variable control mechanism 101", mediated through the optical control mechanism 114, as well as the rate of change of switching events, by the reflected color or intensity mixing. Color or intensity mixing is accomplished by a reflective plate 118. When the reflective plate 118 is rocked by finger pressure on its pivot 119, the white incident light emitted from the fiber optic cable 124 is reflected back with altered color or intensity components. The intensity or color is detected by the photonic sensor 117, electronically processed by the microprocessor 120 and converted to a corresponding current output via the constant current pulse generator 121. The current output is directed to the stimulating needle electrical pin connector 105 by an electrical cable 122 with the return supplied by a second electrical cable 123 to the return electrode 135 located remotely on the skin surface. Just as in the first embodiment, commands to the nerve stimulator can be controlled through switching events, including, but not limited to sequential taps, sudden release or sudden depression.
The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form disclosed, and obviously many modifications and variations are possible in light of the above teaching. For example, although the method of Figure 7 is described as being performed by a microprocessor, the method may be performed by a hard wired system or any other suitable processing system. Additionally, the terms electrical traces and electrical cables is are considered to encompass any type of known electrical conductors, such as, but not limited to metallic wires or non metallic electrical conductors, which may be embedded or non-embedded, and which may be coated with an insulator or non-coated.

Claims

What is Claimed Is:
1. A nerve stimulator needle apparatus comprising: a needle capable of carrying an electric current; a variable control mechanism which is operable to variably control the amplitude of an application of electric current to said needle; a plurality of electrical connectors connected to said variable control mechanism and said needle which allows said variable control mechanism to remotely connect to a nerve stimulation device which is operable to provide a voltage to said variable control mechanism and to provide a current pulse to said needle having an amplitude which is controlled by said variable control mechanism; and a housing which holds said variable control mechanism, said plurality of electrical connectors and said needle.
2. The nerve stimulator needle apparatus of claim 1, wherein said needle is a hypodermic needle, said apparatus further comprising: an injection tube operably connected to said needle to provide a fluid to said needle.
3. The nerve stimulator needle apparatus of claim 2, wherein said housing includes a fluid path, and said injection tube is connected to one end of said fluid path and said needle is connected to another other end of said fluid path.
4. The nerve stimulator needle apparatus of claim 1, wherein said variable control mechanism includes a pressure sensitive switching mechanism which changes the amplitude of said current applied to said needle in relation to the amount of pressure applied to said pressure sensitive switching mechanism.
5. The nerve stimulator needle apparatus of claim 1, wherein said variable control mechanism is operable to increase or decrease current to the needle.
6. The nerve stimulator needle apparatus of claim 1, wherein said variable control mechanism is operable to control a rate of change ofthe current.
7. The nerve stimulator needle apparatus of claim 1, wherein said housing further includes conductive traces which connect said variable control mechanism and said needle to said electrical connectors.
8. The nerve stimulator needle apparatus of claim 1, wherein an electrically resistive layer covers said needle, the resistance of said resistive layer changes with the length of said resistive layer, and an electrical trace from an electrical pin connector provides a voltage to said electrically resistive layer from said nerve stimulator device.
9. The nerve stimulator needle apparatus of claim 8, wherein said needle unit further includes an insulating layer between said electrically resistive layer and said needle.
10. The nerve stimulator needle apparatus of claim 1, wherein said needle unit further includes depth measurement marks which indicate the insertion depth of said needle.
11. The nerve stimulator needle apparatus of claim 1, wherein said variable control mechanism comprises a variable optical switching device.
12. The nerve stimulator needle apparatus of claim 11, wherein said variable optical switching device includes a partially colored plate and a fiber optic cable which directs light from a light source to impinge on said partially colored plate, and directs reflected light from said partially colored plate to a sensor.
13. The nerve stimulator needle apparatus of claim 12, wherein said partially colored plate alters color or intensity components of the light impinged on it from said fiber optic cable in response to an application of pressure.
14. The nerve stimulator needle apparatus of claim 11, wherein said variable optical switching device includes a graduated reflective plate and a fiber optic cable which directs light from a light source to impinge on said graduated reflective plate, and directs reflected light from said graduated reflective plate to a sensor.
15. The nerve stimulator needle apparatus of claim 14, wherein said graduated reflective plate alters color or intensity components of the light impinged on it from said fiber optic cable in response to an application of pressure.
16. The nerve stimulator needle apparatus of claim 1, wherein said needle is an insulated needle.
17. A nerve stimulator apparatus comprising: a nerve stimulator device comprising: a voltage source; a controller; and a current source operable to produce an electrical current in response to said controller; and a needle unit remotely located from said nerve stimulator device and connected to said nerve stimulator device only by at least one electrical conductor, said needle unit comprising: a variable control mechanism which is operable to receive a voltage from said voltage source and to provide instructions to said controller to variably control the amplitude of said electrical current provided by said current source; a needle capable of carrying said electric current from said current source having the amplitude controlled by said variable control mechanism; and a housing which holds said variable control mechanism and said needle.
18. The nerve stimulator apparatus of claim 17, wherein said needle is a hypodermic needle, said apparatus further comprising: an injection tube operably connected to said needle to provide a fluid to said needle.
19. The nerve stimulator apparatus of claim 18, wherein said housing includes a fluid path, and said injection tube is connected to one end of said fluid path and said needle is connected to another other end of said fluid path.
20. The nerve stimulator apparatus of claim 17, wherein said variable control mechanism includes a pressure sensitive switching mechanism which changes the amplitude of said current applied to said needle in relation to the amount of pressure applied to said pressure sensitive switching mechanism.
21. The nerve stimulator apparatus of claim 17, wherein said current source is operable to increase or decrease current in response to the operation of said variable control mechanism, and said variable control mechanism is operable to increase or decrease current to the needle.
22. The nerve stimulator apparatus of claim 17, wherein the current source changes the amplitude of said current in response to the operation of said variable control mechanism and said variable control mechanism is operable to control the rate of change ofthe current.
23. The nerve stimulator apparatus of claim 17, further comprising electrical connectors mounted to said housing, wherein the electric current is provided through said electrical connectors.
24. The nerve stimulator apparatus of claim 23, wherein said housing further includes conductive traces which connect said variable control mechanism and said needle to said electrical connectors.
25. The nerve stimulator apparatus of claim 17, wherein said needle unit includes an electrically resistive layer covering said needle, wherein the resistance of said resistive layer changes with the length of said resistive layer, and an electrical trace from an electrical connector provides a voltage from said voltage source to said electrically resistive layer.
26. The nerve stimulator apparatus of claim 25, wherein said needle unit further includes an insulating layer between said electrically resistive layer and said needle.
27. The nerve stimulator apparatus of claim 17, wherein said needle unit further includes depth measurement marks that indicate the insertion depth of said needle.
28. The nerve stimulator apparatus of claim 25, wherein said controller includes a microprocessor, and said microprocessor determines the insertion depth ofthe needle according to the equation: Lb = (Rt- Ra) / rL where Ra is the resistance of the portion of the needle protruding above a skin surface of a subj ect; Rt is the resistance ofthe total length ofthe needle; ΓL is the resistance per unit length ofthe needle; and L is the insertion depth ofthe needle.
29. The nerve stimulator apparatus of claim 25, wherein the value Ra is calculated from the ratio ofthe applied voltage to the resistive layer on the needle divided by the current detected by a return electrode attached to the surface ofthe skin of a subject.
30. The nerve stimulator apparatus of claim 17, wherein said variable control mechanism comprises a variable optical switching device.
31. The nerve stimulator apparatus of claim 30, wherein said variable optical switching device receives light from a light source and includes a partially colored plate and a fiber optic cable which directs the light from said light source to impinge on said partially colored plate, and directs reflected light from said partially colored plate to a sensor.
32. The nerve stimulator apparatus of claim 31, wherein said partially colored plate alters color or intensity components ofthe light impinged on it from said fiber optic cable in response to an application of pressure, and said sensor converts said altered color or intensity components to a corresponding current signal.
33. The nerve stimulator apparatus of claim 30, wherein said variable optical switching device includes a graduated reflective plate and a fiber optic cable which directs light from a light source to impinge on said graduated reflective plate, and directs reflected light from said graduated reflective plate to a sensor.
34. The nerve stimulator needle apparatus of claim 33, wherein said graduated reflective plate alters color or intensity components of the light impinged on it from said fiber optic cable in response to an application of pressure.
35. The nerve stimulator apparatus of claim 17, wherein said needle is an insulated needle.
36. A method of locating nerves comprising the steps of: (A) inserting a needle mounted on a housing through a surface of skin of a subject; (B) activating a variable control mechanism mounted on said housing to provide a variably controlled current to said needle; (C) monitoring a detected current signal from a return electrode attached to said surface of skin of a subject using a nerve stimulator device, wherein steps A and B are substantially performed simultaneously by the same hand of an operator.
37. The method of locating nerves according to claim 36, further comprising the step of determining the needle insertion depth by providing a voltage to a resistive layer, completing a circuit through a return electrode on the skin surface.
38. The method of locating nerves according to claim 37, wherein the step of determining the needle insertion depth is performed according to the equation: Lb = (Rt- Ra) / rL where Ra is the resistance of the portion of the needle protruding above a skin surface of a subject; Rt is the resistance of the total length of the needle; ΓL is the resistance per unit length ofthe needle; and Lb is the insertion depth ofthe needle.
39. The method of locating nerves according to claim 38, wherein the value Ra is calculated from the ratio ofthe applied voltage to the resistive layer on the needle divided by the current detected by the return electrode attached to the surface of the skin of a subject.
40. The method of locating nerves according to claim 36, wherein the determination ofthe needle depth comprises the steps of: continuously applying a constant current to a resistive layer on the surface of said needle; periodically applying a current pulse to said needle while applying said constant current; waiting for a period of time to elapse after applying said current pulse to said needle and determining the resistance of the resistive layer of said needle exposed from the surface of skin ofthe subject; and calculating the depth of said needle inserted in the surface of skin of the subject.
PCT/US2001/043333 2000-11-24 2001-11-21 Nerve stimulator output control needle with depth determination capability and method of use WO2002055127A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2002555859A JP2004522497A (en) 2000-11-24 2001-11-21 Neurostimulator output control needle with depth determination function and method of using same
CA002429572A CA2429572A1 (en) 2000-11-24 2001-11-21 Nerve stimulator output control needle with depth determination capability and method of use
EP01989097A EP1404214A2 (en) 2000-11-24 2001-11-21 Nerve stimulator output control needle with depth determination capability and method of use
AU2002243217A AU2002243217B2 (en) 2000-11-24 2001-11-21 Nerve stimulator output control needle with depth determination capability and method of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25306400P 2000-11-24 2000-11-24
US60/253,064 2000-11-24

Publications (3)

Publication Number Publication Date
WO2002055127A2 WO2002055127A2 (en) 2002-07-18
WO2002055127A9 true WO2002055127A9 (en) 2003-01-03
WO2002055127A3 WO2002055127A3 (en) 2004-01-08

Family

ID=22958674

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/043333 WO2002055127A2 (en) 2000-11-24 2001-11-21 Nerve stimulator output control needle with depth determination capability and method of use

Country Status (6)

Country Link
US (2) US6706016B2 (en)
EP (1) EP1404214A2 (en)
JP (1) JP2004522497A (en)
AU (1) AU2002243217B2 (en)
CA (1) CA2429572A1 (en)
WO (1) WO2002055127A2 (en)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8611993B2 (en) * 2000-03-13 2013-12-17 Arrow International, Inc. Pre-loaded lockable stimulating catheter for delivery of anaesthetic drugs
US7386341B2 (en) * 2000-03-13 2008-06-10 Arrow International, Inc. Instrument and method for delivery of anaesthetic drugs
US6456874B1 (en) * 2000-03-13 2002-09-24 Arrow International Inc. Instrument for delivery of anaesthetic drug
US7805188B2 (en) * 2000-03-24 2010-09-28 Micor, Inc. Anesthesia conduction catheter for delivery of electrical stimulus
US6663602B2 (en) 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
WO2002043032A2 (en) * 2000-11-21 2002-05-30 Avery Dennison Corporation Display device and methods of manufacture and control
US7338514B2 (en) * 2001-06-01 2008-03-04 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US20030009111A1 (en) * 2001-06-13 2003-01-09 Cory Philip C. Non-invasive method and apparatus for tissue detection
EP1417000B1 (en) 2001-07-11 2018-07-11 Nuvasive, Inc. System for determining nerve proximity during surgery
EP2481338A3 (en) 2001-09-25 2012-09-05 Nuvasive, Inc. System for performing surgical procedures and assessments
US7247149B2 (en) * 2001-12-20 2007-07-24 Advanced Cardiovascular Systems, Inc. Contact and penetration depth sensor for a needle assembly
US10973545B2 (en) 2002-05-31 2021-04-13 Teleflex Life Sciences Limited Powered drivers, intraosseous devices and methods to access bone marrow
US9072543B2 (en) 2002-05-31 2015-07-07 Vidacare LLC Vascular access kits and methods
US20070049945A1 (en) 2002-05-31 2007-03-01 Miller Larry J Apparatus and methods to install, support and/or monitor performance of intraosseous devices
US8690791B2 (en) 2002-05-31 2014-04-08 Vidacare Corporation Apparatus and method to access the bone marrow
US7811260B2 (en) * 2002-05-31 2010-10-12 Vidacare Corporation Apparatus and method to inject fluids into bone marrow and other target sites
US9314228B2 (en) 2002-05-31 2016-04-19 Vidacare LLC Apparatus and method for accessing the bone marrow
US10973532B2 (en) 2002-05-31 2021-04-13 Teleflex Life Sciences Limited Powered drivers, intraosseous devices and methods to access bone marrow
US8142365B2 (en) * 2002-05-31 2012-03-27 Vidacare Corporation Apparatus and method for accessing the bone marrow of the sternum
AU2003231939A1 (en) 2002-05-31 2003-12-19 Vidacare Corporation Apparatus and method to access the bone marrow
US11337728B2 (en) 2002-05-31 2022-05-24 Teleflex Life Sciences Limited Powered drivers, intraosseous devices and methods to access bone marrow
WO2008033873A2 (en) 2006-09-12 2008-03-20 Vidacare Corporation Medical procedures trays and related methods
US11298202B2 (en) 2002-05-31 2022-04-12 Teleflex Life Sciences Limited Biopsy devices and related methods
US8668698B2 (en) 2002-05-31 2014-03-11 Vidacare Corporation Assembly for coupling powered driver with intraosseous device
US9451968B2 (en) 2002-05-31 2016-09-27 Vidacare LLC Powered drivers, intraosseous devices and methods to access bone marrow
US7951089B2 (en) * 2002-05-31 2011-05-31 Vidacare Corporation Apparatus and methods to harvest bone and bone marrow
US8641715B2 (en) 2002-05-31 2014-02-04 Vidacare Corporation Manual intraosseous device
US7582058B1 (en) * 2002-06-26 2009-09-01 Nuvasive, Inc. Surgical access system and related methods
US20050070841A1 (en) * 2002-07-04 2005-03-31 Inovio As Electroporation device and injection apparatus
US7328064B2 (en) 2002-07-04 2008-02-05 Inovio As Electroporation device and injection apparatus
US6951549B1 (en) * 2002-09-30 2005-10-04 Advanced Cardiovascular Systems, Inc. Systems and methods for detecting tissue contact and needle penetration depth
US8137284B2 (en) 2002-10-08 2012-03-20 Nuvasive, Inc. Surgical access system and related methods
US7691057B2 (en) 2003-01-16 2010-04-06 Nuvasive, Inc. Surgical access system and related methods
US7689292B2 (en) * 2003-02-27 2010-03-30 Macosta Medical U.S.A., L.L.C. Nerve stimulation functionality indicator apparatus and method
KR20050105100A (en) * 2003-03-06 2005-11-03 라이프스캔, 인코포레이티드 System and method for piecing dermal tissue
US9504477B2 (en) 2003-05-30 2016-11-29 Vidacare LLC Powered driver
JP4463819B2 (en) 2003-09-25 2010-05-19 ヌヴァシヴ インコーポレイテッド Surgical access system
US7905840B2 (en) 2003-10-17 2011-03-15 Nuvasive, Inc. Surgical access system and related methods
US7815642B2 (en) * 2004-01-26 2010-10-19 Vidacare Corporation Impact-driven intraosseous needle
TWI341738B (en) * 2004-01-26 2011-05-11 Vidacare Corp Apparatus for penetrting a bone and providing access to associated bone marrow
FR2865921B1 (en) * 2004-02-11 2007-06-01 Spinevision EXPLORATION DEVICE FOR TRACKING THE PENETRATION OF AN INSTRUMENT IN AN ANATOMICAL STRUCTURE
FR2868686B1 (en) * 2004-04-09 2007-04-06 Spinevision Sa DEVICE FOR MONITORING THE PENETRATION OF AN INSTRUMENT IN AN ANATOMICAL STRUCTURE COMPRISING AT LEAST ONE REMOVABLE LONGITUDINAL PORTION
CA2470513A1 (en) * 2004-05-14 2005-11-14 David Liepert Retractable needle
US7212865B2 (en) * 2004-05-25 2007-05-01 Philip Cory Nerve stimulator and method
US7315758B2 (en) * 2004-06-03 2008-01-01 Lynntech, Inc. Transdermal delivery of therapeutic agent
US20050283148A1 (en) * 2004-06-17 2005-12-22 Janssen William M Ablation apparatus and system to limit nerve conduction
US10342452B2 (en) * 2004-07-29 2019-07-09 Medtronic Xomed, Inc. Stimulator handpiece for an evoked potential monitoring system
US20060085048A1 (en) * 2004-10-20 2006-04-20 Nervonix, Inc. Algorithms for an active electrode, bioimpedance-based tissue discrimination system
US7865236B2 (en) * 2004-10-20 2011-01-04 Nervonix, Inc. Active electrode, bio-impedance based, tissue discrimination system and methods of use
CA2584760C (en) 2004-10-21 2013-12-24 Novo Nordisk A/S Dial-down mechanism for wind-up pen
US8998848B2 (en) 2004-11-12 2015-04-07 Vidacare LLC Intraosseous device and methods for accessing bone marrow in the sternum and other target areas
WO2006067217A2 (en) * 2004-12-22 2006-06-29 Novo Nordisk A/S Sensor system and method for detecting problems with mounting of skin mountable medical devices
EP1709906A1 (en) * 2005-04-07 2006-10-11 F. Hoffmann-La Roche Ag Method and device for blood sampling
WO2006114396A1 (en) 2005-04-24 2006-11-02 Novo Nordisk A/S Injection device
WO2007024147A1 (en) 2005-08-26 2007-03-01 Fisher & Paykel Healthcare Limited Adjustment mechanism for electrical medical appliances, and methods of use
US10357184B2 (en) * 2012-06-21 2019-07-23 Globus Medical, Inc. Surgical tool systems and method
US8027718B2 (en) * 2006-03-07 2011-09-27 Mayo Foundation For Medical Education And Research Regional anesthetic
WO2007104636A1 (en) * 2006-03-10 2007-09-20 Novo Nordisk A/S An injection device and a method of changing a cartridge in the device
CN101400394B (en) * 2006-03-10 2012-07-04 诺沃-诺迪斯克有限公司 An injection device having a gearing arrangement
CN101405044B (en) * 2006-03-20 2013-10-16 诺沃-诺迪斯克有限公司 Determination of position of injection needle
WO2007121383A2 (en) * 2006-04-13 2007-10-25 Solopower, Inc. Method and apparatus to form thin layers of materials on a base
DE602007004972D1 (en) 2006-05-16 2010-04-08 Novo Nordisk As GEARING MECHANISM FOR AN INJECTION DEVICE
DK2023982T3 (en) 2006-05-18 2012-10-01 Novo Nordisk As Injection device with mode locking means
US20080027520A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Laser treatment of tissue
CN101516286A (en) * 2006-07-28 2009-08-26 特偲芙医药公司 Ablation apparatus and system to limit nerve conduction
ES2805203T3 (en) 2006-09-12 2021-02-11 Teleflex Medical Devices S A R L Bone marrow aspiration and biopsy apparatus
EP2068725B1 (en) * 2006-09-12 2016-11-09 Vidacare LLC Apparatus for biopsy and aspiration of bone marrow
US8944069B2 (en) 2006-09-12 2015-02-03 Vidacare Corporation Assemblies for coupling intraosseous (IO) devices to powered drivers
EP2073728B1 (en) * 2006-09-12 2018-11-07 Teleflex Medical Devices S.à.r.l. Biopsy device
JP5113847B2 (en) 2006-09-29 2013-01-09 ノボ・ノルデイスク・エー/エス Injection device having electronic detection means
US8974410B2 (en) 2006-10-30 2015-03-10 Vidacare LLC Apparatus and methods to communicate fluids and/or support intraosseous devices
US20100168561A1 (en) * 2006-12-18 2010-07-01 Trillium Precision Surgical, Inc. Intraoperative Tissue Mapping and Dissection Systems, Devices, Methods, and Kits
BRPI0809265A2 (en) 2007-03-23 2014-10-07 Novo Nordisk As INJECTION DEVICE INCLUDING A TIGHTENING NUT
FR2917294A1 (en) * 2007-06-14 2008-12-19 Philippe Campana Medical intervention system for e.g. locoregional anesthesia operation, has probe comprising interface for controlling remote control unit that remotely controls controllable additional equipments such as nerve stimulator and syringe-driver
EP2190506B1 (en) 2007-08-17 2011-08-17 Novo Nordisk A/S Medical device with value sensor
US8430920B2 (en) * 2007-09-28 2013-04-30 Kasey K. LI Device and methods for treatment of tissue
US7927281B2 (en) * 2007-10-08 2011-04-19 Jay Wheeler Automated needle pen drug delivery system
US8343079B2 (en) * 2007-10-18 2013-01-01 Innovative Surgical Solutions, Llc Neural monitoring sensor
JP5728231B2 (en) * 2007-12-31 2015-06-03 ノボ・ノルデイスク・エー/エス Electronic monitoring injection device
ES2739877T3 (en) * 2008-01-17 2020-02-04 Inovio Pharmaceuticals Inc Single needle electroporation system of variable current density
DE102008018262B9 (en) * 2008-04-10 2013-07-18 Erbe Elektromedizin Gmbh Surgical device with nerve test device
US7890182B2 (en) 2008-05-15 2011-02-15 Boston Scientific Neuromodulation Corporation Current steering for an implantable stimulator device involving fractionalized stimulation pulses
ITVI20080205A1 (en) * 2008-08-29 2010-02-28 Bioampere Res Srl PERFECTED LOCALIZATION OF NERVOUS TRUNKS FOR LOCO-REGIONAL ANESTHESIA INTERVENTIONS
US8666498B2 (en) 2008-10-27 2014-03-04 Serene Medical, Inc. Treatment of headache
CA2750917A1 (en) 2008-12-26 2010-07-01 Scott Spann Minimally-invasive retroperitoneal lateral approach for spinal surgery
JP5108810B2 (en) * 2009-03-02 2012-12-26 日本電信電話株式会社 Nerve electrode device, method for producing the same, and method for using the same
RU2012107673A (en) 2009-08-04 2013-09-10 Поллоген Лтд. COSMETIC REJUVENATION OF SKIN
KR20120116934A (en) 2009-11-16 2012-10-23 폴로젠 리미티드 Non-invasive fat removal
US11590346B2 (en) 2009-11-16 2023-02-28 Pollogen Ltd. Apparatus and method for cosmetic treatment of human mucosal tissue
CN101804224B (en) * 2010-04-06 2011-11-30 上海塔瑞莎健康科技有限公司 Medical instrument-combined electric pulse introduction device
BR112014016148A8 (en) 2011-12-29 2017-07-04 Novo Nordisk As augmentation / reduction mechanism for automatic injection device and torsion spring-based automatic injection device
US10098585B2 (en) 2013-03-15 2018-10-16 Cadwell Laboratories, Inc. Neuromonitoring systems and methods
US9585618B2 (en) * 2013-09-16 2017-03-07 Empire Technology Development Llc Nerve location detection
US9119628B1 (en) 2015-01-21 2015-09-01 Serene Medical, Inc. Systems and devices to identify and limit nerve conduction
US9113912B1 (en) 2015-01-21 2015-08-25 Serene Medical, Inc. Systems and devices to identify and limit nerve conduction
CN107921256B (en) * 2015-09-18 2022-03-25 沈良洙 Coating method for high-frequency heating needle and high-frequency heating needle
CN105852805B (en) * 2016-03-24 2019-06-11 美合实业(苏州)有限公司 A kind of anesthesia monitor for tumour cutting
US9935395B1 (en) 2017-01-23 2018-04-03 Cadwell Laboratories, Inc. Mass connection plate for electrical connectors
CN107802266A (en) * 2017-11-21 2018-03-16 王冠男 A kind of anesthesia outfit and its application method based on medical nursing
US11253182B2 (en) 2018-05-04 2022-02-22 Cadwell Laboratories, Inc. Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation
US11443649B2 (en) 2018-06-29 2022-09-13 Cadwell Laboratories, Inc. Neurophysiological monitoring training simulator

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299230A (en) * 1979-05-09 1981-11-10 Olympus Optical Co., Ltd. Stabbing apparatus for diagnosis of living body
US4515168A (en) 1983-07-22 1985-05-07 Chester Martin H Clamp-on nerve stimulator and locator
US5389069A (en) * 1988-01-21 1995-02-14 Massachusetts Institute Of Technology Method and apparatus for in vivo electroporation of remote cells and tissue
US5358514A (en) * 1991-12-18 1994-10-25 Alfred E. Mann Foundation For Scientific Research Implantable microdevice with self-attaching electrodes
US5292309A (en) * 1993-01-22 1994-03-08 Schneider (Usa) Inc. Surgical depth measuring instrument and method
US5306236A (en) 1993-02-18 1994-04-26 Vickers Plc Needle electrode for use with hypodermic syringe attachment
US5993434A (en) * 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
US5725514A (en) * 1994-08-15 1998-03-10 A.V.I. - Advanced Visual Instruments, Inc. Adjustable miniature panoramic illumination and infusion system for retinal surgery
AU5448496A (en) * 1995-04-10 1996-10-30 St. Luke's-Roosevelt Hospital Peripheral nerve stimulation device for unassisted nerve blo ckade
US5853373A (en) * 1996-08-05 1998-12-29 Becton, Dickinson And Company Bi-level charge pulse apparatus to facilitate nerve location during peripheral nerve block procedures
US6009347A (en) * 1998-01-27 1999-12-28 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6391005B1 (en) * 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6298256B1 (en) * 1999-09-10 2001-10-02 Frank-Egbert Meyer Device and method for the location and catheterization of the surroundings of a nerve

Also Published As

Publication number Publication date
US7047085B2 (en) 2006-05-16
US20040158304A1 (en) 2004-08-12
AU2002243217B2 (en) 2006-03-16
JP2004522497A (en) 2004-07-29
WO2002055127A3 (en) 2004-01-08
US20020065481A1 (en) 2002-05-30
US6706016B2 (en) 2004-03-16
EP1404214A2 (en) 2004-04-07
WO2002055127A2 (en) 2002-07-18
CA2429572A1 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
US6706016B2 (en) Nerve stimulator output control needle with depth determination capability and method of use
AU2002243217A1 (en) Nerve stimulator output control needle with depth determination capability and method of use
US20080039914A1 (en) Needle with depth determination capability and method of use
US4962766A (en) Nerve locator and stimulator
EP0637934B1 (en) Apparatus for locating a nerve
US6298256B1 (en) Device and method for the location and catheterization of the surroundings of a nerve
US20060195158A1 (en) Nerve Stimulator and Method
AU719246B2 (en) Bi-level charge pulse apparatus to facilitate nerve location during peripheral nerve block procedures
US5081990A (en) Catheter for spinal epidural injection of drugs and measurement of evoked potentials
US6533732B1 (en) Nerve stimulator needle guidance system
US8909334B2 (en) Electrical stimulation device for locating an electrical stimulation point and method
EP0957982A1 (en) Peripheral nerve stimulation device for unassisted nerve blockade
US20100087755A1 (en) Medical/surgical tool for both identifying subcutaneous target tissue by means of emitting an interrogation signal and positioning a catheter at the target
EP2744561B1 (en) Device for administering a pulsed radiofrequency therapy in the vascular system or in other body cavities of the human or animal body
US20090210029A1 (en) Device and method to position a cannula for nerve block
WO2012067879A1 (en) Integrated nerve stimulation and skin marking device and methods of using same
US20080027350A1 (en) Methods and apparatus for localization, diagnosis, contact or activity detection of bio-electric tissue
EP1960039A2 (en) Hyperechoic stimulating block needle
JP2010528769A (en) Continuous nerve block assembly
JP2007502197A (en) Apparatus and method for anesthetic delivery
JP2004016333A (en) Catheter for extradural anesthesia, and electrostimulator using the catheter for extradural anesthesia
EP0823265A2 (en) Needle assembly for electrostimulation of a nerve
WO2003092802A1 (en) Neurostimulating device
Urmey Percutaneous electrode guidance of the block needle for peripheral or plexus neural blockade
DE69533210T2 (en) Voltage control feedback electroporation system for clinical applications

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/11-11/11, DRAWINGS, REPLACED BY NEW PAGES 1/11-11/11; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWE Wipo information: entry into national phase

Ref document number: 2002243217

Country of ref document: AU

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2429572

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002555859

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001989097

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001989097

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001989097

Country of ref document: EP